Group One Trading
XBI icon

Group One Trading’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Group One Trading’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.5M Buy
+90,331
New +$11.3M 0.02% 750
2025
Q4 		– Sell
-24,191
Closed -$2.42M – 9305
2025
Q3 		$2.42M Buy
+24,191
New +$2.18M ﹤0.01% 2113
2025
Q2 		– Sell
-5,605
Closed -$455K – 8757
2025
Q1 		$455K Buy
+5,605
New +$501K ﹤0.01% 3193

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Group One Trading's XBI Position: Q1 2026 in Review

Group One Trading opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q1 2026: 90,331 shares worth $11.5M. The stake represents 0.02% of the portfolio and ranks #750 among its holdings. This is a return to the name: Group One Trading previously reported a position in XBI as recently as Q3 2025.

Group One Trading first reported a position in XBI in Q1 2025 and has held it in 3 quarters since. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Group One Trading held 90,331 shares of State Street SPDR S&P Biotech ETF worth $11.5M as of Q1 2026.
  • State Street SPDR S&P Biotech ETF was a new Group One Trading position in Q1 2026.
  • State Street SPDR S&P Biotech ETF made up 0.02% of Group One Trading's portfolio in Q1 2026, its #750 holding.
  • Group One Trading first reported a position in State Street SPDR S&P Biotech ETF in Q1 2025 and has held it in 3 quarters since.
  • 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.